Late Phase II Study of Recombinant IL-1.BETA. Derivative(OCT-43) in Patients With Mycosis Fungoides.

Skin Cancer
doi 10.5227/skincancer.10.104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Japanese Skin Cancer Society

Related search

Risk of Cutaneous Malignancy in Mycosis Fungoides Patients Treated With PUVA: A Retrospective Study

Turk Dermatoloji Dergisi
Dermatology
2015English

Mycosis Fungoides

Archives of Dermatology
2000English

Folliculotropic Mycosis Fungoides

Archives of Dermatology
2010English

Management of Mycosis Fungoides

Journal of the Royal Society of Medicine
Medicine
1979English

Pemphigus Vulgaris in Association With Mycosis Fungoides

Scripta Medica
2009English

Efficacy of Mogamulizumab in Previously Treated Patients With Less Advanced Mycosis Fungoides: Results From the Mavoric Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Hypopigmentation: Mycosis Fungoides in Disguise

BMJ Case Reports
Medicine
2014English

Long-Term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome

Archives of Dermatology
2003English

Study of Anti-Tumor Activing of IL-1.BETA. ( OCT-43 ) Nude Mouse Transplantabile Human Malignant Melanoma ( SK-14 Strain ) and Renal Cancer ( RCC-1 Strain ).

Skin Cancer
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy